Applications of Boc-(S)-3-Amino-4-(2-Thienyl)-Butyric Acid in Industrial Manufacturing

Boc-(S)-3-Amino-4-(2-Thienyl)-Butyric Acid serves as a specialized intermediate for advanced chemical synthesis. As an original manufacturer, we support various high-value production streams using this chiral component. Below, we detail its integration into multiple industrial sectors with clear compliance, blending, process, and output guidance.

1. Peptide Synthesis for Research and Pharmaceutical Development

This compound provides a stereocontrolled building block for assembling peptides containing a thienyl-modified side chain, frequently required in lead optimization for pharmaceutical pipelines. Chemists use it during stepwise solid-phase or solution-phase synthesis to introduce unique structural features into peptide chains for preclinical and clinical candidates. The protected amino group maintains integrity throughout multi-step coupling and deprotection cycles, supporting high-purity, quality-controlled active pharmaceutical ingredient (API) production.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP Chapter <1045> Biotechnology-Derived Articles
• European Pharmacopoeia (Ph. Eur.) guidelines for amino acid derivatives
• FDA 21 CFR Part 211 Current Good Manufacturing Practice for Finished Pharmaceuticals

Typical usage ratio

• 1.0–2.2 equivalents per coupling step in solid-phase peptide synthesis, precisely controlled by resin loading and chain length
• Solution-phase: 0.9–1.1 molar equivalents with direct coupling agents

Downstream process integration

• Added during amino acid elongation steps as a protected monomer
• Deprotection occurs after final chain assembly, followed by HPLC purification
• Extensively tested for optical purity and residual solvent levels prior to peptide release

Final product types

• Modified peptide drug candidates
• Diagnostic peptide standards
• Chiral reference materials for research
• Bioactive peptide fragments for in vivo studies

2. Chiral Intermediate for API Synthesis in Small Molecule Drugs

The acid enables selective construction of chiral centers in target molecules, essential for producing high-purity APIs containing thienyl functional groups. Medicinal chemists employ it in enantioselective alkylation and coupling reactions. The Boc protecting group allows for staged functionalization, improving yields and ensuring structural integrity during scale-up manufacturing, especially in pilot and commercial pharmaceutical synthesis environments.

Industry compliance standards

• ICH Q11 Development and Manufacture of Drug Substances
• Ph. Eur. 2.2.46 Chromatographic purity requirements
• FDA 21 CFR Part 210 for manufacturing, processing, and packing
• cGMP guidelines for chemical intermediates

Typical usage ratio

• 20–30% molar ratio in key chiral step, adjusted by target product and reaction stoichiometry
• Smaller-scale screenings may range from 5–10% of total batch input for pilot batches

Downstream process integration

• Inserted at pre-coupling or condensation stage for chiral core development
• Protecting group removed prior to final ring closure and functionalization
• Intermediate subjected to chromatographic purification and stereospecific analysis

Final product types

• Thienyl-substituted small molecule APIs
• Pharmaceutical enantiomeric reference compounds
• Investigational New Drugs (INDs) for thienyl derivatives
• Non-clinical toxicology batch samples for regulatory submissions

3. Custom Synthesis of Fluorescent and Bioactive Probes

Biotech and diagnostics companies incorporate Boc-protected amino acids with thienyl groups to build custom fluorescent tags and bioactive molecules. These probes assist in cellular imaging, assay development, and mechanistic biological research. Controlled deprotection steps enable site-specific binding or conjugation to fluorophores, supporting strict quality and reproducibility requirements in reagent manufacturing.

Industry compliance standards

• ISO 13485 Quality management for medical devices
• ISO/IEC 17025 Testing and calibration laboratories
• OECD guidelines for Good Laboratory Practice (GLP)
• REACH (EC 1907/2006) chemical safety assessment and labeling

Typical usage ratio

• Typically 1 equivalent per label or tag conjugation site
• Adjustments based on desired probe brightness and specificity, usually 0.8–1.2 equivalents for best coupling efficiency

Downstream process integration

• Activated and coupled during probe assembly after linker attachment
• Selective deprotection before or after fluorophore introduction, depending on labeling strategy
• Final purification by preparative liquid chromatography

Final product types

• Thienyl-labeled peptide probes
• Cellular imaging reagents
• Bioassay substrates
• Protein interaction tracers for in vitro diagnostics

4. Key Component for Custom Amino Acid Derivatives in Fine Chemicals

Manufacturers of fine chemical intermediates and specialty amino acids utilize this derivative to create non-canonical amino acids for specialty reagents or biochemical tool compounds. The thienyl substitution delivers unique electronic and steric properties. Operators apply rigorous process controls to achieve high conversion in amidation or esterification reactions, supporting advanced syntheses for academic and commercial customers.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems
• Responsible Care Global Charter for chemical manufacturing
• REACH registration for specialty chemicals
• Transport compliance under IATA/IMDG where applicable

Typical usage ratio

• Used at 30–70% molar input relative to total batch size
• Blending ratios depend on functional group substitution patterns required by customer

Downstream process integration

• Introduced at the protected monomer stage during amidation
• Boc group removed for subsequent side-chain modification
• Strict in-process controls for reaction time and temperature to maintain chirality

Final product types

• Thienyl-functionalized specialty amino acids
• Protected building blocks for combinatorial libraries
• Fine chemical intermediates for contract research
• Bulk chiral material for academic synthesis or custom reference standards